Market Tracker

02/24 5:16pm ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

42.72
Delayed Data
As of Feb 24
 -0.36 / -0.84%
Today’s Change
32.18
Today|||52-Week Range
55.15
+10.39%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close43.08
Today’s open42.78
Day’s range41.89 - 43.14
Volume651,609
Average volume (3 months)1,060,775
Market cap$3.7B
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-55.24%
Earnings growth (this year)-43.28%
Earnings growth (next 5 years)-32.75%
Revenue growth (last year)-24.12%
P/E ratioNM
Price/Sales223.72
Price/Book11.79

Competitors

 Today’s
change
Today’s
% change
TECHBio-Techne Corp+0.25+0.24%
BLUEbluebird bio Inc+3.70+4.73%
KITEKite Pharma Inc-0.37-0.70%
XONIntrexon Corp-0.12-0.54%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$15.0M
Annual profit (last year)-$141.1M
Net profit margin-940.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Kevin Charles Gorman
President, Chief Operating &
Financial Officer
David-Alexandre C. Gros
Corporate headquarters
San Diego, California

Forecasts